Tissue-resident memory T (Trm) cells contribute to local immune protection in non-lymphoid tissues such as skin and mucosa, but little is known about their transcriptional regulation. Here we showed that CD8 + CD103 + Trm cells, independent of circulating memory T cells, were sufficient for protection against infection and described molecular elements that were crucial for their development in skin and lung. We demonstrated that the T-box transcription factors (TFs) Eomes and T-bet combined to control CD8 + CD103 + Trm cell formation, such that their coordinate downregulation was crucial for TGF-b cytokine signaling. TGF-b signaling, in turn, resulted in reciprocal T-box TF downregulation. However, whereas extinguishment of Eomes was necessary for CD8 + CD103 + Trm cell development, residual T-bet expression maintained cell surface interleukin-15 (IL-15) receptor b-chain (CD122) expression and thus IL-15 responsiveness. These findings indicate that the T-box TFs control the two cytokines, TGF-b and IL-15, which are pivotal for CD8 + CD103 + Trm cell development and survival.
+ Trm cell formation. Although both T-box transcription factors must be downregulated, Eomes must be completely extinguished, whereas residual T-bet expression is essential for IL-15-mediated long-term survival.
SUMMARY
Tissue-resident memory T (Trm) cells contribute to local immune protection in non-lymphoid tissues such as skin and mucosa, but little is known about their transcriptional regulation. Here we showed that CD8 + CD103 + Trm cells, independent of circulating memory T cells, were sufficient for protection against infection and described molecular elements that were crucial for their development in skin and lung. We demonstrated that the T-box transcription factors (TFs) Eomes and T-bet combined to control CD8 + CD103 + Trm cell formation, such that their coordinate downregulation was crucial for TGF-b cytokine signaling. TGF-b signaling, in turn, resulted in reciprocal T-box TF downregulation. However, whereas extinguishment of Eomes was necessary for CD8 + CD103 + Trm cell development, residual T-bet expression maintained cell surface interleukin-15 (IL-15) receptor b-chain (CD122) expression and thus IL-15 responsiveness. These findings indicate that the T-box TFs control the two cytokines, TGF-b and IL-15, which are pivotal for CD8 + CD103
+
INTRODUCTION
Memory CD8 + T cells in the blood have traditionally been classified as belonging to one of two subsets: central memory T (Tcm) cells that express the lymphoid homing markers CCR7 and CD62L, and effector memory T (Tem) cells that largely lack these receptors but instead express markers that allow them to enter peripheral tissues (Sallusto et al., 1999) . When memory T cells were detected in the periphery, it was previously thought that these were Tem cells in transit through the body (Masopust et al., 2001; Reinhardt et al., 2001 ). However, more recent studies have determined that a proportion of T cells found in the tissues do not recirculate and instead represent a distinct population of tissue-resident memory T (Trm) cells. Initially described in detail in the skin (Gebhardt et al., 2009 ) and gut (Masopust et al., 2010) , these cells have now been found in a variety of tissues and organs in both humans and mice (Casey et al., 2012; Sathaliyawala et al., 2013) . Trm cells often carry markers that are largely absent from memory cells in the circulation. Two such molecules are surface-expressed CD69 and CD103 (Mackay et al., 2013) . CD69 is usually seen as an activation marker, but it can be upregulated in an antigen-independent fashion on T cells found in peripheral tissues (Casey et al., 2012; Mackay et al., 2013; Shin and Iwasaki, 2012) . CD103, which is the integrin aEb7, is driven by local transforming growth factor b (TGF-b) and its appearance is delayed in comparison to CD69 (Mackay et al., 2013) . Although CD103 detection was originally used in the early analyses of Trm cell development and function (Gebhardt et al., 2009; Masopust et al., 2010) , more recent discussions have focused on a broader Trm cell definition (Steinert et al., 2015; Thome et al., 2014; Watanabe et al., 2015) . CD69 is found on the majority of Trm cells regardless of CD103 expression, and bona fide CD69 + CD103
À Trm cells have clearly been shown to exist (Steinert et al., 2015; Watanabe et al., 2015) . However, given that CD69 is upregulated quite early in Trm cell development, at a time when tissue-egress mechanisms are not completely extinguished (Mackay et al., 2013; Skon et al., 2013) , it remains possible that a fraction of T cells expressing this molecule can still return to the circulation. Thus, CD69 might not be a reliable marker of obligatory residency. This is particularly pertinent in the case of peripheral tissues such as skin, which contain a number of distinct resident and recirculating populations (Watanabe et al., 2015) . In addition, Trm cell activation can promote recruitment of cells from the circulation (Schenkel et al., 2013) , complicating the relative contribution of resident and recirculating T cells to overall peripheral immune control. In contrast to this uncertainty regarding CD69 + Trm cells, the CD103 + subset of CD8 + Trm cells are likely to represent a truly resident population in a variety of critical locations. These cells dominate the epithelia of the small intestine and skin, where they remain in disequilibrium from the blood over the long term (Jiang et al., 2012; Klonowski et al., 2004) . Such surfaces are common pathogen entry points in the body, indicating that the intraepithelial CD8 + CD103 + Trm cells might provide the first linedefense against many infectious agents. The CD8 + CD103 + Trm cells are transcriptionally distinct from their CD103 negative tissue counterparts (Bergsbaken and Bevan, 2015; Wakim et al., 2012) , as well as from Tem and Tcm cells in the circulation (Mackay et al., 2013) . It has been shown that CD103 induction requires either local antigen recognition by Trm cells or their specific localization within the tissue (Mackay et al., 2012; Wakim et al., 2010) , arguing that CD103 + Trm cells likely represent late-stage tissue residents (Mackay et al., 2013) . One common feature of the mature CD8 + CD103 + Trm cells in a range of different tissues is the near-extinguishment of Eomesodermin (Eomes) (Mackay et al., 2013; Wakim et al., 2012) . Eomes is a T-box transcription factor (TF), which, along with the related homolog T-bet, is a major player in shaping the development of a range of cells belonging to the innate and adaptive arms of the immune system (Kaech and Cui, 2012) . Eomes expression is upregulated in long-lived memory cells, whereas T-bet expression is highest in short-lived effector cells (Joshi et al., 2007) . In terms of tissue T cells, it is known that T-bet downregulation is required for optimal CD8 + CD103 + Trm cell development or survival in the lung (Laidlaw et al., 2014) . However, T-bet and Eomes share cooperative functions (Banerjee et al., 2010; Intlekofer et al., 2005; Pearce et al., 2003) , indicating that Eomes modulation might also play an equally important role in Trm cell formation.
Here we examined how the combination of T-bet and Eomes controlled Trm cell development, focusing on CD8 + CD103 + Trm cells, which we showed had stand-alone protective capabilities in the absence of any contribution from the circulation. We further showed that the coordinated downregulation of both T-box TFs was required for optimal TGF-b signaling, leading to efficient CD8 + CD103 + Trm cell development. However, while Eomes was effectively extinguished during Trm cell development, there was residual T-bet expression. The latter promoted interleukin-15 receptor (IL-15R) b-chain (CD122) expression and was required for long-term Trm cell survival. Therefore, while Trm cell development required the downregulation of both T-box TFs, the contribution of T-bet was distinct in that ongoing low-level expression of this TF was necessary to maintain IL-15 signaling and CD8 + CD103 + Trm cell development and survival.
RESULTS

CD8
+ CD103 + Trm Cells Protect Skin against Herpes Simplex Virus Infection in the Absence of Circulating Memory T Cell Contribution Trm cells can recruit memory T cells from the blood (Schenkel et al., 2013) , which leaves open the possibility that Trm cellmediated protection is completely dependent on the presence of circulating T cells. We wanted to see whether CD8 + Trm cells alone could control infection in the absence of input from the circulating memory pool. To do this, we took advantage of the observation that systemic treatment with depleting antibodies eliminates circulating T cells, including memory cells, while leaving peripheral populations largely intact (Schenkel et al., 2013) . To this end, we adoptively transferred in vitroactivated congenically marked Thy1.1 + transgenic (gBT-I)
T cells specific for the immunodominant determinant from herpes simplex virus (HSV) and then recruited them into the skin of C57BL/6 recipient mice via the induction of a local nonspecific inflammatory reaction using the contact sensitizer DNFB, as previously described (Mackay et al., 2012) . Intravenous administration of anti-Thy1.1 antibody was then used to eliminate all circulating HSV-specific T cells, including gBT-I T cells in the spleen, while sparing the Trm cell counterparts in the skin ( Figure 1A ). At the time of treatment (4 weeks after DNFB induced Trm cell lodgement), around 30% of skin gBT-I T cells were negative for CD103 and a high proportion of these expressed CD69 ( Figure 1B ). The anti-Thy1.1 antibody selectively eliminated all cells lacking CD103, which included a fraction of cells that expressed only CD69. There was virtually no loss of CD103 + gBT-I T cells, defining them as separate from the circulation and thus true resident cells. To examine the functional capabilities of CD8 + CD103 + Trm cells, we then challenged antibody-ablated and control mice with HSV on the left (DNFB treated) flank that contained the Trm cells (in the gBT-I group) and right flank lacking this population (Ctrl). The presence of infectious virus was assessed 6 days later. The results in Figure 1C show that CD103 + Trm cells effectively controlled local HSV replication in the absence of the circulating populations. Combined, these results define the CD103 + subset of CD8 + Trm cells as a true tissue-resident population that can directly protect skin against HSV challenge in the absence of circulating antigen-specific memory T cells.
T-box Transcription Factors Are Downregulated during CD8 + CD103 + Trm Cell Maturation with Complete Shut-Down of Eomes Expression We had previously carried out a detailed comparison of genes differently regulated in memory T cells resident in a variety of tissues to identify a core transcriptional signature of the CD103 + Trm cell population (Mackay et al., 2013) . As part of this signature, we found that Eomes transcription was strikingly downregulated in CD8 + CD103 + Trm cells compared to circulating Tem or Tcm populations. Because both T-box TFs Eomes and T-bet can influence memory T cell development (Kaech and Cui, 2012) , we were interested in tracking their coordinated expression during Trm cell maturation. Figure 2A shows that skin memory gBT-I T cells had no detectable intracellular Eomes expression after the resolution of HSV replication, whereas their splenic counterparts were Eomes positive. At this time, T-bet expression was similarly downregulated in skin memory T cells, although less so than Eomes (Figure 2A) .
One of the advantages of the HSV skin infection model is that the development of skin Trm cells and the acquisition of the mature CD103 + phenotype occurs in a progressive fashion, from the time T cells enter the skin during the effector response, to their entry into the epidermal layer and finally their surface acquisition of CD103 (Mackay et al., 2013) . This allows the fine delineation of the molecular changes that occur during Trm cell maturation, as it is easy to separate epidermis (consisting exclusively of epithelium) from the dermis (which is largely nonepithelium, except for the hair follicles). Quantitative PCR (qPCR) analysis showed that virus-specific T cells had high Eomes transcript levels just after infection was cleared from the skin at day 8 after inoculation ( Figure 2B ). Transcription of this gene was progressively extinguished as the T cells subsequently migrated from the dermis to the epidermis and then in the latter compartment, converted to the mature CD103 + form.
This Eomes shut-down in skin T cells was also evident at the protein level, as determined by flow cytometry ( Figure 2C ). At later times after the resolution of HSV skin infection, most gBT-I T cells localized to the epithelium, such that by 4 weeks after infection, the pattern of staining for whole skin and epidermis had coalesced ( Figure 2C ). T-bet protein levels also declined after HSV infection ( Figure 2D ), although not to the same extent as seen with Eomes. Overall, these results show that expression of both T-box TFs is downregulated during CD8 + Trm cell development in the skin, with the lowest amounts found in the most mature CD103 + subset in the epidermis.
Forced Expression of T-box Transcription Factors Inhibits Trm Cell Formation in the Skin Epidermis
The data suggested that T-box TF downregulation might be required for Trm cell formation. To formally prove this, we forced the expression of either Eomes or T-bet in maturing Trm cells. We had previously shown that activated CD8 + T cells injected into mouse skin are able to migrate into the epidermis and form stable Trm cells (Mackay et al., 2013) . This approach allowed us to test whether T cells transduced to express Eomes or T-bet using recombinant retrovirus would be compromised in their ability to migrate to the epidermis and acquire the mature CD103 + Trm cell phenotype.
Infection with recombinant retroviruses resulted in approximately 60%-90% transformation of T cells as determined by GFP expression. The transduced cells had high levels of T-box TF expression compared to cells transduced with the control retrovirus ( Figure S1A ). Overexpression of either Eomes or T-bet did not change the expression of various surface markers such as CD44, Ly6C, and chemokine receptors CCR7 and CXCR6 ( Figure S1B ). In contrast, T cells transduced with the T-bet expression vector displayed higher levels of CD122 and CXCR3, both known to be induced by this TF (Matsuda et al., 2007) , whereas the Eomes-containing vector resulted in a slight reduction in the latter molecule.
Retrovirus-transduced CD8 + T cells were transferred by intradermal injection and identified in recipient mice as shown in Figure S1C . Some transferred cells were retained in the skin, while others made their way to the circulation and could be found in the spleen. Recovery of injected cells from the spleen was not affected by the forced Eomes expression, while there were far fewer Eomes-transduced T cells in the epidermal layer at either 4 or > 14 days after intradermal injection ( Figure 3A ) compared to cells transduced with control vectors. Thus, Eomes expression significantly inhibited CD103 + Trm cell development (as detectable by day 14). Importantly, high T-bet expression had a similar effect, with T-bet transduced cells being severely compromised in their ability to form Trm cells in the epidermis ( Figure 3B ). Therefore, downregulation of T-box TF expression is required for epidermal entry and/or survival, and CD8 + CD103 + Trm cell formation in skin.
T-box Transcription Factors and TGF-b Receptor
Signaling Operate in a Feed-Forward Loop, Which Is Required for Efficient Trm Cell Formation in the Skin Epidermis We and others have shown that TGF-b is required for Trm cell development in peripheral tissues such as the skin and gut, and that this cytokine drives the upregulation of the Trm cell markers CD103 and to a lesser extent CD69 (Casey et al., 2012; Mackay et al., 2013; Sheridan et al., 2014; Skon et al., 2013; Zhang and Bevan, 2013) . Furthermore, it has been shown that TGF-b signals can negatively regulate T-bet expression in CD8 + T cells (Laidlaw et al., 2014) . We therefore wanted to determine when TGF-b signaling was required during Trm cell maturation, and whether this correlated with the downregulation of the other T-box TF Eomes, as well as T-bet. Wild-type OT-I T cells (specific for ovalbumin [OVA] ) and TGF-bR deficient OT-I T cells (OT-I.Tgfbr2 f/f Lck-Cre; henceforth referred to as OTI.Tgfbr2 À/À ) were transferred into mice that were subjected to infection with recombinant HSV expressing ovalbumin (HSV-OVA). As shown in Figure 4A , similar numbers of wild-type and TGF-bR deficient cells infiltrated infected skin early after infection. However, whereas wild-type cells upregulated CD103, the TGF-bR-deficient cells failed to do so ( Figure 4B ). OT-I T cells unable to respond to TGF-b signals were significantly impaired in their ability to enter and/or survive in the epidermal layer and were significantly reduced in number in this compartment compared to their wild-type counterparts after HSV infection ( Figure 4A , right panel) or following in vitro activation and intradermal transfer ( Figure S2A , right panel). Not only were the TGF-bR deficient cells inefficient in epidermal entry and Trm cell formation, but they also expressed higher levels of both Eomes and T-bet in skin and epidermis ( Figure 4C ) demonstrating a role for TGF-b in downregulating the T-box TFs in these Trm cell-forming compartments. Note that Eomes and T-bet expression levels were unchanged on OT-I T cells in the circulation. In addition, we also found a reverse association between TGF-bR itself and T-box TFs. Retrovirustransduced cells that expressed high levels of Eomes or T-bet showed depressed levels of TGF-bR expression (Figures 4D and S2B) . In line with this, forced expression of these TFs resulted in an inability to respond to TGF-b signals, as detected by CD103 upregulation (Figures 4E and S2C) . Moreover, following the transfer of Eomes and T-bet overexpressing cells into the skin, we found reduced expression of CD69 and the integrin CD49a ( Figure S2D ), which are Trm cell-associated molecules dependent on TGF-b signaling (Zhang and Bevan, 2013 skin at early times after transfer ( Figure S2D ), and cells lacking this integrin subunit were not compromised in lodgement or survival for at least 14 days after transfer ( Figure S2E ). Combined, the data suggest that T-box TFs and the cytokine TGF-b operate in a feedforward loop during Trm cell development, where TGF-b drives the downregulation of the T-box TFs, which in turn promotes increased signaling via the cytokine receptor. Given that forced T-bet expression inhibited skin Trm cell formation, we wanted to determine whether its downregulation would promote early development of these memory cells. It should be noted that here we only focus on initial Trm cell lodgement (up to day 7), with longer-term survival examined in the next section. We began by using T cells homozygous or heterozygous for
T-bet Elimination Results in
Tbx21 (the gene encoding T-bet), which express lower amounts of T-bet. Although it has been reported that complete loss of T-bet results in increased Eomes expression (Takemoto et al., 2006) , this is not the case for the OT-I T cells after HSV-OVA infection ( Figure S3A ). Thus, all changes in Eomes expression in skin memory Tbx21 panel), the latter due to the requirement for T-bet to generate a complete short-lived effector cell pool following viral infection (Joshi et al., 2007) . The proportion of total skin T cells expressing the mature CD103 + Trm cell phenotype was significantly higher in the Tbx21 +/À cells ( Figure 5A , right panel). Thus, even a modest reduction in T-bet promoted Trm cell formation. Given the above, we wanted to determine whether complete elimination of T-bet would also promote greater lodgement of Trm cell precursors in the skin. Wild-type Tbx21 +/+ or Tbx21
OT-I T cells were transferred into recipient mice, which were then infected with HSV-OVA. As expected, Tbx21 À/À cells in both spleen and skin showed a preferential skewing toward cells with low KLRG-1 expression ( Figure 5B ), which are the precursors of Trm cells (Mackay et al., 2013) . Consistent with this increased precursor frequency, T-bet-deficient T cells were recovered in significantly greater numbers from the skin at day 7 post infection compared to their wild-type counterparts.
Furthermore, a larger proportion of T-bet-deficient cells expressed CD103 ( Figure 5C, D) . Thus, complete elimination of T-bet expression results in the preferential production of KLRG-1 À memory cell precursors, with a concomitant increase in CD103 + Trm cell lodgement early after the resolution of skin infection.
T-bet-Deficient Trm Cells Show Defective IL-15Rb Expression and Aberrant Cytokine Production and Disappear from the Skin over Time
Despite the enhanced CD103 + Trm cell formation by T-bet deficient OT-I T cells seen at day 7 post infection ( Figure 5C ), the vast majority of these cells were lost by day 14 from the skin ( Figure 6A ). T-bet deficient CD103 + Trm cells remaining at day 14 after HSV infection showed lower Bcl-2 levels, suggesting that survival in these few cells was also likely to be compromised ( Figure S4A ). Tbx21 À/À Trm cells could not be rescued by Eomes overexpression ( Figure S4B ), indicating that Eomes was either deleterious for Trm cell formation or that it simply could not efficiently substitute for T-bet in this particular subset. In contrast, T-bet deficient memory T cells in the circulation maintained Eomes expression ( Figure S3A ), unlike their CD103 + counterparts in the skin that downregulate this TF as part of their maturation program (Figures 2 and S3B) . The preferential loss of T-bet-deficient Trm cells compared to their wild-type counterparts was also seen following injection of in vitro activated CD8 + Tbx21 À/À T cells directly into the skin (Figures 6B and S4C) . Note that OT-I T cells heterozygous for T-bet were not lost from the skin, but instead were biased toward the CD103 + Trm cell phenotype when compared to wild-type cells ( Figure 6C ). Thus, T-bet-deficient cells are lost over time despite their superior lodgement in skin early after infection. In contrast, Eomes deficiency was compatible with normal Trm cell development and maintenance in the skin ( Figures S4D and S4E ). These data established that the complete loss of T-bet, but not Eomes, was detrimental to long-term Trm cell survival. T-bet-deficient CD103 + Trm cells in the skin downregulated
Eomes expression similar to their wild-type counterparts, effectively rendering them devoid of all T-box TF activity ( Figure S3B ). It has been reported that T cells lacking both Eomes and T-bet have defective expression of the b-chain (CD122) of the IL-15 receptor (Intlekofer et al., 2005) . Given this, we hypothesized that impaired survival of T-bet deficient Trm cells was due to defective IL-15 signaling. In line with this idea, we found defective CD122 expression specifically in CD103 + Tbx21 À/À Trm cells that had downregulated Eomes early during maturation (Figure 6D ). CD122 expression remained decreased on Tbx21 
Tbx21
À/À CD8 + T cells lodged by direct intradermal injection ( Figure 6E , middle panel) even at later times clearly implicating impaired IL-15 signaling in the impaired survival of T-bet deficient Trm cells. In contrast, CD122 expression levels were equivalent between wildtype OT-I and OT-I.Tbx21 +/À T cells ( Figure 6E , right panel), which was consistent with their similar survival in skin. In addition to the lack of CD122 expression, we found that T-bet deficient skin T cells that downregulated Eomes made less IFN-g and secreted IL-17 with concomitant RORgt upregulation ( Figure 6F ). CD8 + T cells deficient for both Eomes and T-bet have been shown to ectopically upregulate RORgt and IL-17 (Intlekofer et al., 2008) , so the altered cytokine production was consistent with T-bet deficient skin T cells being effectively T-box TF negative once Eomes is downregulated. Thus, loss of T-bet has a profound effect on both Trm cell survival and the pattern of cytokine expression, which is likely linked to the downregulation of Eomes during the final stages of Trm cell development.
IL-15 Signaling Is Required for Ongoing Trm Cell Survival in Non-lymphoid Tissues
The concomitant failure in CD122 upregulation and Trm cell persistence of T-bet deficient T cells is consistent with the established role of IL-15 signaling in Trm cell development (Mackay et al., 2013) . While Trm cell development was found to be impaired in IL-15 deficient mice, it was not clear whether the cytokine was just required for Trm cell formation or whether it also played a role in their subsequent survival. To address this, we administered neutralizing antibody specifically targeting the IL-15 and IL-15R complex. This antibody was injected into the skin flank at the site of Trm cell establishment, at two different periods following infection with HSV. We found that the number of skin Trm cells was diminished by more than half following antibody administration relatively early during the Trm cell formation phase (treatment day 7-13 post infection [p.i.] HSV, Figure 7A ), and also long after the Trm cell pool had been established (treatment > day 30 p.i. HSV, Figure 7B ). Therefore, ongoing IL-15 signaling is required for skin Trm cell survival. To extend our observation to another setting, we examined the IL-15 dependence of lung Trm cells. For these experiments, we transferred OT-I T cells into C57BL/6 mice and infected with recombinant influenza virus expressing the target determinant from ovalbumin (X31-OVA). Similar to CD8 + CD103 + Trm cells in the skin, the corresponding subset in lungs showed downregulation of Eomes and T-bet expression ( Figure S5A ) with the decrease in Eomes and T-bet most pronounced in the mature CD103 + population ( Figures S5B and S5C) . Moreover, similar to our results in the skin, T-bet elimination resulted in a pronounced loss of CD8 + CD103 + Trm cells from the lung by day 14 after infection despite enhanced early lodgement (Figure S5D) . Neutralization of the IL-15 and IL-15R complex by antibody injection showed that Trm cell survival in the lung was IL-15 dependent ( Figure 7C ). Interestingly, when we separately examined lung memory T cells based on their relative expression of CD103, only the CD103 + T cells showed this reliance on IL-15 for ongoing survival ( Figure 7C , right panel). Overall, the combined data suggest that skin and lung CD8 + CD103 + Trm cells mirror each other in T-box TF requirements and, most critically, in their dependence on IL-15 signaling.
DISCUSSION
It is now emerging that Trm cells consist of different subsets, with varying expression of the markers CD69 and CD103 (Steinert et al., 2015; Watanabe et al., 2015) . The CD8 + CD103 + Trm cells form a transcriptionally distinct group (Wakim et al., 2012) , which is found in a variety of different non-lymphoid organs, including the lung, skin, gut, and thymus (Casey et al., 2012; Hofmann et al., 2013; Hu et al., 2015; Mackay et al., 2013) . In our study, we used antibody ablation to formalize two important characteristics for this population. First, we demonstrated that the CD8 + CD103 + Trm cells have stand-alone protective capability. This is critical, because prior assessments of Trm cell-mediated protection were done in the presence of circulating memory cells (Mackay et al., 2012; Schenkel et al., 2014; Shin and Iwasaki, 2012) , leaving open the possibility that infection control involved or even relied on recruitment from the blood. Separately, the experiments also showed that CD8 + CD103 + skin T cells were truly resident, as distinct from a subset of skin T cells that only expressed CD69 and were eliminated by antibody depletion. While it has been shown that CD69 + CD103 À T cells do not recirculate in some circumstances (Bergsbaken and Bevan, 2015; Steinert et al., 2015) , our results argue that caution should be exercised when using CD69 as the sole Trm cell marker. Having established the credentials for CD8 + CD103 + Trm cells, we then focused on elucidating the role of the T-box TFs T-bet and Eomes during their development. While the importance of T-bet downregulation had been flagged by Laidlaw et al. (2014) for CD8 + CD103 + Trm cells in the lung, those studies stopped short of examining the combined T-box TFs Eomes and T-bet as well as determining how they separately controlled Trm cell development. We found that, like T-bet, Eomes was also downregulated during Trm cell development, although to a much greater extent. Skin Trm cells virtually extinguish Eomes expression and do so quite late in the maturation program, either just before or just after the cells enter the epithelium and prior to the appearance of cell surface CD103. Leaving the matter of Eomes levels aside for the time being, the co-ordinated downregulation of both T-box TFs represents a pivotal step in Trm cell formation, since it was found to result in enhanced TGF-b signaling. This cytokine has been shown to be critical for CD8 + CD103 + Trm cell development in a variety of tissues (Sheridan et al., 2014; Zhang and Bevan, 2013) . We found that TGF-b signaling downregulated the T-box TFs, suggesting these both this cytokine and the T-box TFs are involved a feedforward loop that optimizes CD8 + CD103 + Trm cell formation.
At face value, the earlier demonstration that T-bet modulation drove lung CD8 + CD103 + Trm cell development (Laidlaw et al., 2014) implied that its complete elimination would have much the same effect. Initially, we found this to be the case, with T-bet deficient CD8 + T cells showing early lodgement in the skin and acquisition of the mature CD103 + phenotype. Moreover, the enhancement correlated with an increase in Trm cell precursor frequencies. T-bet deficiency favors development of KLRG-1 À CD127 + memory precursor effector cells (MPECs) (Joshi et al., 2007) , which are also the CD8 + CD103 + Trm cell precursors (Mackay et al., 2013; Sheridan et al., 2014) . In skin, KLRG-1-MPECs migrate into the epidermis after the resolution of HSV infection to form epidermal-lodged Trm cells (Mackay et al., 2013) . In a related fashion, Sheridan et al. (2014) (Mackay et al., 2013; Wakim et al., 2012) . This means that in cells that are genetically defective in Tbx21, Eomes extinguishment results in complete loss of T-box TF expression. Total T-box deficiency in CD8 + T cells leads to altered functionality for this subset, with decreased IFN-g production offset by the appearance of RORgt and IL-17 (Intlekofer et al., 2008) . In line with this, we found that a proportion of T-bet deficient cells that downregulated Eomes could express RORgt and IL-17. More importantly, Intlekofer et al. (2005) also showed that at least one T-box TF was necessary to maintain expression of the cytokine receptor subunit CD122. As a consequence, skin T cells that genetically lacked T-bet and downregulated Eomes had little surface expression of the IL-15R b-chain. IL-15 is a prerequisite for Trm cell development (Mackay et al., 2013) and, as shown here in experiments using anti-IL-15 and IL-15R antibody blockade, it is also critical to the survival of Trm cells once lodged in the skin. Therefore, our results reveal a Trm cell-T-bet dependency that is linked to IL-15 signaling and set up by the loss of Eomes during the maturation process.
Putting the mechanisms described here in a broader context of tissue residency, the association between IL-15 and T-bet dependency for skin Trm cells mirrors what has been reported for tissue-resident cells that form part of the innate system. Tissue-resident NK cells in skin and liver show similar patterns of low Eomes expression as well as IL-15 and T-bet-dependence (Sojka et al., 2014) . In terms of other innate cells, CD8aa TCRab CD103 + intra-epithelial lymphocytes (IELs) that reside in the intestinal mucosa appear to have a similar multifactorial dependence (Klose et al., 2014; Reis et al., 2014) . These natural IELs are Eomes lo and derive from distinct thymic T cell precursors that mature in the intestine in a TGF-b-and IL-15-dependent manner (Cheroutre et al., 2011) . The IL-15 dependence for the CD8aa IELs is a consequence of T-bet driven CD122 expression (Reis et al., 2014) , matching the results here for CD8 + CD103 + Trm cells in both the skin and lung. Thus, some of the transcriptional regulations defined here for Trm cells are likely to be common to a variety of tissue-resident cells from both the innate and adaptive arms of the immune response. In summary, our data reveal that both Eomes and T-bet are tightly regulated during Trm cell development and provide a critical interface with the cytokines TGF-b and IL-15. The Eomes extinguishment during the final stages of maturation renders skin CD8 + CD103 + Trm cells completely T-bet dependent for their survival. One could envisage that under certain circumstances, elements involved in Trm cell development might be replaced by related factors, such as other cytokines that signal through of common g-chain receptors acting as alternatives to IL-15. Given the complexity of this system and interdependence between the various components, changes that affect parameters such as the timing of T-box TF modulation and the coordination with TGF-b availability would also have a profound effect on Trm cell maturation. This, in turn, would directly affect the extent to which CD8 + CD103 + Trm cells dominate the local response and mediate immunity within a given tissue. Understanding the various drivers of Trm cell development will permit optimization of their lodgement or survival for more effective immunity at pathogen entry points throughout the body. 
Virus Infections and Determination of Viral Titers
Viruses used were the KOS strain of HSV-1 (HSV) and HSV-OVA (Mackay et al., 2013) . Epicutaneous infection by scarification was carried out using 1 3 10 6 PFU HSV as described (Gebhardt et al., 2009) . For influenza infections, 1 3 10 4 PFU X31-OVA (kindly provided by S. Turner) was administered intranasally. The level of infectious virus following HSV was determined within homogenized skin by standard PFU assays.
T Cell Transfers and In Vitro Activation
Adoptive transfers of naive gBT-I or OT-I T cells were carried out intravenously (i.v.) with lymph node suspensions. Naive gBT-I or OT-I T cells were transferred at a total number of 5 3 10 4 or 2.5 3 10 4 cells/population in co-transfer experiments, where cell types were transferred at a ratio of 1:1. For polyclonal in vitro activation of CD8 + T cells, CD8-enriched splenocytes were activated by anti-CD3ε (145-2C11) and anti-CD28 (37.51) (5 mg/ml, eBioscience). For experiments where T cells were transferred by intradermal injection, 1-5 3 10 6 activated cells were transferred into recipients as described (Mackay et al., 2013) . For experiments utilizing DNFB to lodge Trm cells for HSV challenge experiments, 1 3 10 7 gBT-I.Thy1.1 + T cells were transferred i.v. and the skin flank was treated with 0.3% DNFB (Sigma-Aldrich), as described (Mackay et al., 2012) .
Cytokine Treatments
For IL-15 blocking assays, mice were treated with anti-IL-15+IL-15R a chain antibody (7.5 mg/d, eBioscience) for 6 consecutive days by either intradermal injection (for experiments using HSV) or intraperitoneal injection (for experiments using influenza). For CD103 upregulation in vitro, CD8 + T cells were treated for 48 hr with 5 ng/ml recombinant TGF-b. For depletion of circulating memory cells, mice were treated by intraperitoneal injection with 1 mg antibody to Thy1.1 (HIS51, BD Biosciences).
Retroviral Constructs and Transduction of CD8 + T Cells
Murine stem cell virus (MSCV)-T-bet-internal ribosome entry site (IRES)-GFP has been previously described (Joshi et al., 2007) , and MSCV-Eomes-IRES-GFP and MSCV-IRES-GFP were provided by Professor Gabrielle Belz (WEHI). In vitro activated CD8 + T cells were spin-infected with retroviral supernatant 2d following activation in the presence of 1 mg/mL polybrene (Sigma-Aldrich) and 50 U/mL IL-2, and then expanded for a further 2-4 days in IL-2-containing medium. Transduction efficacy was determined by GFP expression and transduced cells (CD45.1 + ) were transferred into C57BL/6 recipients by intradermal injection.
Flow Cytometry and Antibodies T cells were recovered from skin as described (Mackay et al., 2012) . Briefly, skin tissue was incubated for 90 min at 37 C in dispase (2.5mg/ml) followed by the separation of epidermis and dermis. Epidermal sheets were subsequently incubated for 30 min in trypsin/EDTA and remaining skin tissue was chopped into small fragments and incubated for 30 min at 37 C in collagenase type 3 (3 mg/ml). For recovery of T cells from the lung, mice were injected i.v. with 3 mg of Alexa Fluor 700-conjugated antibody to CD3 10 min prior to sacrifice, and mice were then perfused before the collection of lung tissue that was digested for 90 min in collagenase type 3 (3 mg/ml). Cell suspensions were stained with antibodies for flow cytometry. For intracellular staining, cells were fixed using Foxp3/Transcription Factor Staining Buffer Set (eBioscience) before staining with intracellular antibodies. For intracellular cytokine secretion assays, cells were incubated for 4 hr with PMA and Ionomycin in the presence of Brefeldin A. The following antibodies were purchased from BD PharMingen: anti-CD45.1 (A20), ÀCD45.2 (104), ÀVa2 (B20.1), ÀCD8a (53-6.7), ÀTCR-b (H57-597), ÀBcl-2 (3F11), and IL-17A (Tc11-18H10). The following antibodies were purchased from eBioscience: anti-CD45.1 (A20), ÀCD45.2 (104), ÀCD8a (53-6.7), ÀCD3 (500A2), anti-CD103 (2E7), ÀKLRG1 (2F1), CD122 (TM-b1), T-bet (4B10) Eomes (Dan11mag), and RORgt (AFKJS-9); anti-CXCR3 and -TGF-bRII were purchased from R&D. cDNA synthesis, preamplification and qPCR were performed using Taqman Gene Expression Cells-To-Ct Kit, Taqman Fast Preamp master mix and Taqman assays. The threshold cycle of respective genes for each cell population was normalized to the mean of Hprt, b2m, and Tbp (DCt). Normalized gene expression was compared to that of the Trm cell population according to the 2 -DDCT method.
Statistical Analysis
All statistics were calculated using the two-tailed Mann-Whitney test and GraphPad Prism (GraphPad Software). * p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. 
SUPPLEMENTAL INFORMATION
